Skip to Main Content

Paper Details

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.
Clin Cancer Res
54
2019
Author NameAffiliation
Naseema GangatMayo Clinic
Ronan Swords
Justin M WattsSylvester Cancer Center, University of Miami
  • 1 - 3

Datasets

Release 1.2